Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data
Authors
Keywords
-
Journal
Modern Rheumatology
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-06-19
DOI
10.1080/14397595.2020.1784556
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study
- (2018) Arun Kumar A. U. et al. PLoS One
- Medication adherence among patients with gout: A systematic review and meta-analysis
- (2018) Lieke E.J.M. Scheepers et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
- (2018) Kenjiro Kimura et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Increasing trend of asymptomatic hyperuricemia under treatment with urate-lowering drugs in Japan
- (2018) Masayuki Hakoda et al. Modern Rheumatology
- Effects of Febuxostat in Early Gout
- (2017) Nicola Dalbeth et al. Arthritis & Rheumatology
- Treat-to-target (T2T) recommendations for gout
- (2016) U Kiltz et al. ANNALS OF THE RHEUMATIC DISEASES
- 2016 updated EULAR evidence-based recommendations for the management of gout
- (2016) P Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
- (2016) Tatsuo Hosoya et al. CLINICAL RHEUMATOLOGY
- Gout
- (2016) Nicola Dalbeth et al. LANCET
- Global epidemiology of gout: prevalence, incidence and risk factors
- (2015) Chang-Fu Kuo et al. Nature Reviews Rheumatology
- Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis
- (2015) Robert Jackson et al. BMJ Open
- Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis
- (2015) Rui Liu et al. Biomed Research International
- Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
- (2014) Chang-Fu Kuo et al. ANNALS OF THE RHEUMATIC DISEASES
- Achieving Serum Urate Goal: A Comparative Effectiveness Study between Allopurinol and Febuxostat
- (2014) Hind Hatoum et al. POSTGRADUATE MEDICINE
- An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan
- (2012) Naoyuki Kamatani et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
- (2011) Yanyan Zhu et al. ARTHRITIS AND RHEUMATISM
- Relationship between physician specialty and allopurinol prescribing patterns: a study of patients with gout in managed care settings
- (2011) Bhavik J. Pandya et al. CURRENT MEDICAL RESEARCH AND OPINION
- Frequency and risk factors of gout flares in a large population-based cohort of incident gout
- (2011) D. Rothenbacher et al. RHEUMATOLOGY
- Gout and hyperuricemia in young people
- (2010) Hisashi Yamanaka CURRENT OPINION IN RHEUMATOLOGY
- Development of a Database of Health Insurance Claims: Standardization of Disease Classifications and Anonymous Record Linkage
- (2010) Shinya Kimura et al. JOURNAL OF EPIDEMIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started